An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
Event or Problem Description
The customer stated that a corrected report was required for architect ca 19-9xr testing for one patient being monitored to aid in cancer management.An initial result of 2911 u/ml was corrected to 2058 u/ml.No adverse impact to patient management was reported.
Additional Manufacturer Narrative
After further evaluation, the suspect medical device was changed from architect ca 19-9xr, list number 02k91-29, manufacturing site abbott (b)(4) of this report to architect i2000sr analyzer, list 03m74-02, manufacturing site irving, texas.Manufacturer report number 1628664-2017-00202 has been submitted and all further information will be documented under that number.